Rheosorbilact® is a national scientific asset, since it was developed by Ukrainian professionals.

This is one of the most balanced solutions: rational combination of components complementing and potentiating each other’s action; the product provides comprehensive pharmacological effects.

All components have iso-osmotic concentrations, which minimizes side effects and provides osmolality by three times higher than that of blood plasma (0.9 vs. 0.29 osmol/l) in aggregate.

The solution’s hyperosmolalilty provides expressed detoxification effect and potent hemodynamic action, improves blood microcirculation and rheology.

After invention of Rheosorbilact®, a multicomponent polyfunctional solution, it became clear that monocomponent solutions (5 % glucose solution, 0.9 % sodium chloride solution) are increasingly becoming history.

RHEOSORBILACT® is the basis for contemporary treatment of internal diseases: small volume infusion therapy.

How supplied
200 ml
400 ml
Sales markets

Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Turkmenistan, Uganda, Uzbekistan, Ukraine.